Research Article
Factors Contributing to Diagnosis and Prognosis in Sinonasal Malignancies
Table 1
Clinical data of 39 patients with malignant tumor of nasal cavity and sinus.
| | Category | Case | Mean survival time (months) | Median survival time (months) |
| | Pathological type | | | | | Melanocytoma melanoma | 2 | 67 | 67 | | Undifferentiated intermorphic carcinoma | 1 | 132 | 132 | | Granulocytic sarcoma | 1 | 26 | 26 | | Adenocarcinoma | 7 | 49.3 | 58 | | Mucoepidermoid carcinoma | 1 | 30 | 30 | | Lymphoma | 8 | 32.6 | 20.5 | | Squamous carcinoma and neuroendocrine | 1 | 79 | 79 | | Squamous carcinoma | 11 | 36.8 | 32 | | Myofibroblastoma | 1 | 73 | 73 | | Malignant fibrous histiocytoma | 1 | 14 | 14 | | Round cell malignancy | 1 | 16 | 16 | | Neuroendocrine | 3 | 43.3 | 45 | | Sarcoma | 1 | 11 | 11 | | Treatment method | | | | | Surgery+radioterapy+chemotherapy | 7 | 62.6 | 69 | | Surgery+chemotherapy | 3 | 13 | 7 | | Untreated | 3 | 12.3 | 10 | | Surgery | 12 | 38.9 | 35.5 | | Surgery+radioterapy | 8 | 53.3 | 55.5 | | Radiotherapy | 1 | 110 | 110 | | Not detailed | 1 | 17 | 17 | | Radiotherapy+chemotherapy | 3 | 37 | 13 | | Chemotherapy | 1 | 11 | 11 | | Clinical stage | | | | | Stage I | 7 | 74.7 | 77 | | Stage II | 8 | 71.7 | 71 | | Stage III | 7 | 52.3 | 58 | | Stage IV | 17 | 18.3 | 14 |
|
|